Founded in May 2017 and based at the Babraham Research Campus in Cambridge, PredictImmune develops pioneering tools for guiding treatment options in immune-mediated inflammatory diseases like Crohn’s and ulcerative colitis (IBD).
Based on ten years of research at Cambridge University, PredictImmune’s test kits help both clinicians and patients to understand, at the point of diagnosis, the likely course of disease and opens the possibility of better treatment choices from the outset.
Business funding insights
How to grow your company through acquisition
Gurinder Sunner, head of BGF in the Midlands considers ‘How to grow your company through acquisition’ In its simplest form,…
Infrastructure spending is only one part of the solution
The chancellor is right to back an investment-led recovery, but infrastructure is only part of the solution. Business funding is needed too.